ropinirole has been researched along with Disorders of Excessive Somnolence in 8 studies
Disorders of Excessive Somnolence: Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders (e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME) and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause (e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME). (From J Neurol Sci 1998 Jan 8;153(2):192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320)
| Excerpt | Relevance | Reference |
|---|---|---|
| " We observed a negative correlation between the severity of daytime sleepiness and renal function in patients treated with pramipexole alone (r(s) = -0." | 5.15 | Effect of chronic kidney disease on excessive daytime sleepiness in Parkinson disease. ( Abe, H; Baba, Y; Fukuyama, K; Higuchi, MA; Inoue, T; Uehara, Y; Yamada, T, 2011) |
| "Patients with Parkinson disease (PD) treated with the nonergot dopamine agonists pramipexole dihydrochloride and ropinirole hydrochloride have been reported to have sleep attacks without warning." | 3.72 | Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. ( Lang, AE; Razmy, A; Shapiro, CM, 2004) |
| "Ropinirole therapy was not associated with daytime episodes of rapid eyes movement (REM) sleep." | 2.70 | Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers. ( Ferreira, JJ; Galitzky, M; Montastruc, JL; Rascol, O; Sampaio, C; Thalamas, C; Tiberge, M, 2002) |
| "Patients with Parkinson's disease using pramipexole or ropinirole are at higher risk of experiencing somnolence relative to patients taking placebo." | 2.41 | Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials. ( Etminan, M; Rochon, PA; Samii, A; Takkouche, B, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Léger, D | 1 |
| Ogrizek, P | 1 |
| Baba, Y | 1 |
| Higuchi, MA | 1 |
| Fukuyama, K | 1 |
| Abe, H | 1 |
| Uehara, Y | 1 |
| Inoue, T | 1 |
| Yamada, T | 1 |
| Nissen, T | 1 |
| Newman, EJ | 1 |
| Grosset, KA | 1 |
| Daghem, M | 1 |
| Pal, G | 1 |
| Stewart, M | 1 |
| Odin, P | 1 |
| Macphee, GJ | 1 |
| Grosset, DG | 1 |
| Homann, CN | 1 |
| Wenzel, K | 1 |
| Suppan, K | 1 |
| Ivanic, G | 1 |
| Crevenna, R | 1 |
| Ott, E | 1 |
| Razmy, A | 1 |
| Lang, AE | 1 |
| Shapiro, CM | 1 |
| Pirker, W | 1 |
| Happe, S | 1 |
| Etminan, M | 1 |
| Samii, A | 1 |
| Takkouche, B | 1 |
| Rochon, PA | 1 |
| Ferreira, JJ | 1 |
| Galitzky, M | 1 |
| Thalamas, C | 1 |
| Tiberge, M | 1 |
| Montastruc, JL | 1 |
| Sampaio, C | 1 |
| Rascol, O | 1 |
3 reviews available for ropinirole and Disorders of Excessive Somnolence
| Article | Year |
|---|---|
[Sleep disorders in adults].
Topics: Adult; Benzodiazepines; Diagnosis, Differential; Disorders of Excessive Somnolence; Dopamine Agonist | 2008 |
Sleep attacks--facts and fiction: a critical review.
Topics: Antiparkinson Agents; Benzothiazoles; Central Nervous System Stimulants; Disorders of Excessive Somn | 2003 |
Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials.
Topics: Antiparkinson Agents; Benzothiazoles; Disorders of Excessive Somnolence; Dopamine Agonists; Drug The | 2001 |
2 trials available for ropinirole and Disorders of Excessive Somnolence
| Article | Year |
|---|---|
Effect of chronic kidney disease on excessive daytime sleepiness in Parkinson disease.
Topics: Aged; Benzothiazoles; Comorbidity; Disorders of Excessive Somnolence; Dopamine Agonists; Female; Hum | 2011 |
Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers.
Topics: Cross-Over Studies; Disorders of Excessive Somnolence; Dopamine Agonists; Double-Blind Method; Human | 2002 |
3 other studies available for ropinirole and Disorders of Excessive Somnolence
| Article | Year |
|---|---|
Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Confidence Intervals; Disorders of Excessive Somnolence; | 2012 |
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
Topics: Aged; Benzothiazoles; Bromocriptine; Disorders of Excessive Somnolence; Dopamine Agonists; Dose-Resp | 2004 |
Sleep attacks in Parkinson's disease.
Topics: Antiparkinson Agents; Disorders of Excessive Somnolence; Dopamine Agonists; Humans; Indoles; Male; M | 2000 |